Twist Bioscience Corp — Director's Dealing 2020

Sep 11, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Twist Bioscience Corp (TWST)
CIK: 0001581280
Period of Report: 2020-09-09

Reporting Person: THORBURN JAMES M (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-09-09	Common Stock	M	20000	$26.66	Acquired	71719	Direct
2020-09-09	Common Stock	S	18000	$65.9042	Disposed	53719	Direct
2020-09-09	Common Stock	S	2000	$66.4243	Disposed	51719	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-09-09	Employee Stock Option (right to buy)	$26.66	M	20000	Disposed	2028-11-18	Common Stock (20000)	Direct

Footnotes

F1: Represents the weighted average sales price per share. The shares sold at prices ranging from $65.37 to $66.36 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

F2: Represents the weighted average sales price per share. The shares sold at prices ranging from $66.37 to $66.53 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

F3: The option is immediately exercisable. 20% of the shares subject to the option vested on October 31, 2019, and 1/60th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.